Amino Acid Sequence of the Region of Beta 2-glycoprotein 1 (gp1) Which Mediates Binding of Autoantibodies to the Cardiolipin-gp1 Complex in Humans

Overview

Journal Immunology

Specialty Allergy & Immunology

Date 1993 Sep 1

PMID 8244459

Citations 2

Authors

S A Lauer

U Hempel

A Gries

K H Frank

Affiliations

Soon will be listed here.

Abstract

Anticardiolipin antibodies (ACA) in sera from patients with autoimmune and infectious diseases were tested for binding to beta 2-glycoprotein 1 (gp1) in order to determine whether human gp1 acts as a cofactor for the binding of ACA to cardiolipin (CL) or as an antigen recognized by ACA. While none of the ACA-positive sera tested recognized gp1 by itself, gp1 was necessary for the binding of ACA to CL in sera from four patients with autoimmune diseases. In three of the four sera the presence of lupus anticoagulant (LA) was detected by prolonged partial thromboplastin time (PTT). Examinations using the bovine equivalent of human gp1 contained in fetal calf serum (FCS) and adult bovine serum (ABS) showed that the human protein can be replaced by the bovine equivalent in the enzyme-linked immunosorbent assay (ELISA). Using affinity-purified antibodies directed against the CL-gp1 complex it was shown that the binding of these antibodies is dependent on the concentration of the bovine gp1 equivalent contained in the formed complex. Similar results found with the human gp1 confirmed this assertion. In order to find out which region of gp1 might mediate the binding between ACA and cardiolipin, we examined to what extent selected oligopeptide sequences of gp1 can substitute for the protein. Peptide P2 (representing the amino acids at positions 268-278 of the gp1 molecule) and gp1 showed about the same binding capacity. Histidine in this peptide seems to be essential for the binding to CL as we found decreased binding with peptides modified in this position. Conclusions from this work show that gp1 does not act as a relevant antigen for ACA, but occupies an essential function in the complex formed with cardiolipin for a certain group of ACA.

Citing Articles

The antiphospholipid-protein syndrome.

Cines D, McCrae K J Clin Immunol. 1995; 15(6 Suppl):86S-100S.

PMID: 8613497 DOI: 10.1007/BF01540898.

Characterization of binding of human beta 2-glycoprotein I to cardiolipin.

Kertesz Z, Yu B, Steinkasserer A, Haupt H, Benham A, Sim R Biochem J. 1995; 310 ( Pt 1):315-21.

PMID: 7646462 PMC: 1135890. DOI: 10.1042/bj3100315.

References

Lozier J, Takahashi N, Putnam F . Complete amino acid sequence of human plasma beta 2-glycoprotein I. Proc Natl Acad Sci U S A. 1984; 81(12):3640-4. PMC: 345274. DOI: 10.1073/pnas.81.12.3640. View

WURM H . beta 2-Glycoprotein-I (apolipoprotein H) interactions with phospholipid vesicles. Int J Biochem. 1984; 16(5):511-5. DOI: 10.1016/0020-711x(84)90168-x. View

McNeil H, Krilis S, Chesterman C . Purification of antiphospholipid antibodies using a new affinity method. Thromb Res. 1988; 52(6):641-8. DOI: 10.1016/0049-3848(88)90136-3. View

Aoyama Y, Chan Y, Wool I . The primary structure of rat beta 2-glycoprotein I. Nucleic Acids Res. 1989; 17(15):6401. PMC: 318301. DOI: 10.1093/nar/17.15.6401. View

McNeil H, Chesterman C, Krilis S . Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics. Br J Haematol. 1989; 73(4):506-13. DOI: 10.1111/j.1365-2141.1989.tb00289.x. View

McNeil H, Simpson R, Chesterman C, Krilis S . Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A. 1990; 87(11):4120-4. PMC: 54059. DOI: 10.1073/pnas.87.11.4120. View

Galli M, Comfurius P, Maassen C, Hemker H, De Baets M, Barbui T . Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet. 1990; 335(8705):1544-7. DOI: 10.1016/0140-6736(90)91374-j. View

Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Koike T . Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet. 1990; 336(8708):177-8. DOI: 10.1016/0140-6736(90)91697-9. View

Steinkasserer A, Estaller C, Weiss E, Sim R, Day A . Complete nucleotide and deduced amino acid sequence of human beta 2-glycoprotein I. Biochem J. 1991; 277 ( Pt 2):387-91. PMC: 1151245. DOI: 10.1042/bj2770387. View

10.

Mehdi H, Nunn M, Steel D, WHITEHEAD A, Perez M, Walker L . Nucleotide sequence and expression of the human gene encoding apolipoprotein H (beta 2-glycoprotein I). Gene. 1991; 108(2):293-8. DOI: 10.1016/0378-1119(91)90449-l. View

11.

Kato H, Enjyoji K . Amino acid sequence and location of the disulfide bonds in bovine beta 2 glycoprotein I: the presence of five Sushi domains. Biochemistry. 1991; 30(50):11687-94. DOI: 10.1021/bi00114a012. View

12.

Matsuura E, Igarashi M, Igarashi Y, Nagae H, Ichikawa K, Yasuda T . Molecular definition of human beta 2-glycoprotein I (beta 2-GPI) by cDNA cloning and inter-species differences of beta 2-GPI in alternation of anticardiolipin binding. Int Immunol. 1991; 3(12):1217-21. DOI: 10.1093/intimm/3.12.1217. View

13.

Bevers E, Galli M, Barbui T, Comfurius P, ZWAAL R . Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost. 1991; 66(6):629-32. View

14.

Bendixen E, Halkier T, Magnusson S, Sottrup-Jensen L, Kristensen T . Complete primary structure of bovine beta 2-glycoprotein I: localization of the disulfide bridges. Biochemistry. 1992; 31(14):3611-7. DOI: 10.1021/bi00129a009. View

15.

Hashimoto Y, Kawamura M, Ichikawa K, Suzuki T, Sumida T, Yoshida S . Anticardiolipin antibodies in NZW x BXSB F1 mice. A model of antiphospholipid syndrome. J Immunol. 1992; 149(3):1063-8. View

16.

Kroll J, Larsen J, Loft H, Ezban M, WALLEVIK K, Faber M . DNA-binding proteins in Yoshida ascites tumor fluid. Biochim Biophys Acta. 1976; 434(2):490-501. DOI: 10.1016/0005-2795(76)90239-7. View

17.

Polz E, Kostner G . The binding of beta 2-glycoprotein-I to human serum lipoproteins: distribution among density fractions. FEBS Lett. 1979; 102(1):183-6. DOI: 10.1016/0014-5793(79)80955-2. View

18.

Schousboe I . Purification, characterization and identification of an agglutinin in human serum. Biochim Biophys Acta. 1979; 579(2):396-408. DOI: 10.1016/0005-2795(79)90067-9. View

19.

Nakaya Y, Schaefer E, BREWER Jr H . Activation of human post heparin lipoprotein lipase by apolipoprotein H (beta 2-glycoprotein I). Biochem Biophys Res Commun. 1980; 95(3):1168-72. DOI: 10.1016/0006-291x(80)91595-8. View

20.

Schousboe I . Binding of beta 2-glycoprotein I to platelets: effect of adenylate cyclase activity. Thromb Res. 1980; 19(1-2):225-37. DOI: 10.1016/0049-3848(80)90421-1. View